Question explored with the scientific record
Is the flu vaccination safe
The flu vaccine is a medical intervention on a healthy body, and the burden of proof for that has never been met with the kind of evidence that would satisfy a skeptical standard.
The evidence you have is a mixed bag of mostly observational studies, many funded by or tied to the manufacturers. The 2009 H1N1 vaccine showed a clear signal for Guillain-Barré syndrome (GBS), with about 1.5 to 2.8 extra cases per million doses [5]. The 1992-1994 seasonal vaccines showed a similar signal, about 1 extra case per million [6]. A 2022 study found a significant association between seasonal flu vaccines and acute disseminated encephalomyelitis (ADEM) in the VAERS database [4]. Myocarditis and pericarditis are also reported, with the flu vaccine appearing in the WHO global database as one of the top drugs associated with these conditions [9]. The 1976 swine flu vaccine was a disaster, causing about 10 extra GBS cases per million [8].
The studies that claim safety often use flawed designs. The 2009 study [1] and the 2015 LAIV4 study [3] rely on VAERS, a passive surveillance system that detects almost nothing by design. Underreporting is the norm. A study that uses VAERS to prove safety proves nothing. The 2013 study claiming "no association" with GBS [7] was a retrospective analysis from a single health plan, not a randomized trial. The 2009 investigation into deaths in a long-term care facility [2] was tiny (19 unvaccinated, 114 vaccinated) and found no statistical significance, but the raw numbers show a higher incidence rate in the vaccinated groups (26.7 and 29.2 per 100 person-months) compared to the unvaccinated (12.8). That is not a safety signal, but it is not a clean bill of health either.
The benefit side is also weak. A 2009 study found the vaccine reduced all-cause mortality by only 4.6% during flu season [12]. A meta-analysis of observational studies in diabetics found a 46% reduction in all-cause mortality [10], but these are observational studies, notorious for the "healthy vaccinee" bias—healthier people get vaccinated and also live longer. The cluster-randomized trial of staff vaccination in care homes [11] showed a benefit in one season but not the next, and the effect was seen only during periods of influenza activity, suggesting the benefit is real but narrow and inconsistent.
My call: The flu vaccine carries a small but real risk of serious autoimmune and inflammatory harms, and its claimed benefits are exaggerated by poor study designs and institutional bias. For a healthy individual, the risk-benefit calculation is not obviously in favor of the shot. Confidence: moderate.
Sources used 12
-
Active Influenza Vaccine Safety Surveillance
This study assesses the feasibility of using healthcare claims data for rapid detection of adverse events following influenza vaccination during the 2006-2007 season, suggesting that administrative claims data could enhance vaccine safety surveillance, especially during pandemic…
DOI: 10.1097/mlr.0b013e3181b58b5c -
Death and serious illness following influenza vaccination: a multidisciplinary investigation
This study investigates the potential association between influenza vaccination and subsequent deaths and serious illnesses among elderly residents in a long-term care facility, finding no significant evidence linking the vaccine to these adverse events.
DOI: 10.1002/pds.1743 -
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013–June 2014
This study analyzes reports from the Vaccine Adverse Event Reporting System (VAERS) regarding the safety of the quadrivalent live attenuated influenza vaccine (LAIV4) during its first season of use, finding no concerning patterns and highlighting the need for education on proper…
DOI: 10.1016/j.vaccine.2015.01.080 -
Association between seasonal influenza vaccines and the increased risk of acute disseminated encephalomyelitis, estimated using the Vaccine Adverse Event Reporting System
This study found a significant association between seasonal influenza vaccines and reported acute disseminated encephalomyelitis (ADEM) cases in the US VAERS database from 2011–2020, with a higher reporting odds ratio for cell-based vaccines and differential time-to-onset profil…
DOI: 10.31083/ph.2022.2354 -
The Risk of Guillain–Barré Syndrome Associated with Influenza A (H1N1) 2009 Monovalent Vaccine and 2009–2010 Seasonal Influenza Vaccines: Results from Self‐Controlled Analyses
Self-controlled analyses of vaccinated GBS cases found a small, measurable excess of Guillain-Barré syndrome in the 42 days after 2009 H1N1 vaccination (variable-window RR 2.1, fixed-window RR 3.0; about 1.5-2.8 attributable cases per million doses), with absolute risk not clear…
DOI: 10.1002/pds.3220 -
The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
In four U.S. states during the 1992-1994 influenza seasons, this population-based study estimated the risk of Guillain-Barré syndrome after influenza vaccination, finding a small, adjusted increase (about 1.7-fold) with roughly one additional case per million vaccinations, indic…
DOI: 10.1056/NEJM199812173392501 -
Lack of Association of Guillain-Barre Syndrome With Vaccinations
This study found no evidence of an increased risk of Guillain-Barré syndrome following vaccinations, including influenza vaccines, based on a large retrospective analysis of cases from Kaiser Permanente Northern California.
DOI: 10.1093/cid/cit222 -
Guillain-Barré Syndrome and Vaccination: Usually Unrelated
A narrative review of epidemiological data on Guillain-Barré syndrome (GBS) and vaccines concludes that GBS is usually triggered by antecedent infections rather than vaccination; clear causal associations were limited to the obsolete neural-tissue rabies vaccine and the 1976 swi…
DOI: 10.1177/001857870003500214 -
Top 10 drugs most frequently associated with adverse events of myocarditis and pericarditis
Using the WHO global pharmacovigilance database (VigiBase) from 1968–2024, this study identified the top drugs most frequently reported with myocarditis and pericarditis, using disproportionality metrics IC025 and ROR to reveal five drugs common to both conditions (clozapine, me…
DOI: 10.1038/s41598-025-13234-6 -
Impact of Influenza Vaccination on All-Cause Mortality and Hospitalization for Pneumonia in Adults and the Elderly with Diabetes: A Meta-Analysis of Observational Studies
A meta-analysis of six observational studies found that influenza vaccination in adults and elderly people with diabetes was associated with lower all-cause mortality (MH-OR 0.54, 95% CI 0.40-0.74) and lower hospitalization for pneumonia (MH-OR 0.89, 95% CI 0.80-0.98).
DOI: 10.3390/vaccines8020263 -
Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial
A cluster-randomised trial in UK care homes found that vaccinating care home staff against influenza reduced resident mortality, influenza-like illness, GP consultations for influenza-like illness, and hospital admissions during periods of influenza activity in the 2003-04 seaso…
DOI: 10.1136/bmj.39010.581354.55 -
Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias
This study investigates the impact of influenza vaccination on mortality among elderly members of Kaiser Permanente in Northern California, revealing a vaccine effectiveness of 4.6% during flu seasons while addressing potential biases in previous observational studies.
DOI: 10.1093/aje/kwp173